Related Experiment Video

Updated: Jun 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Novel MYBPC3 mutations in Chinese patients with hypertrophic cardiomyopathy]

Zhan-feng Ma1, Wen-ling Liu, Da-yi Hu

  • 1Department of Cardiology, Peking University People's Hospital, Beijing 100044, China.

Zhonghua Xin Xue Guan Bing Za Zhi
|December 22, 2009
PubMed

Insights

MYBPC3 gene mutations were screened in Han Chinese patients with hypertrophic cardiomyopathy (HCM). Four novel mutations were found in 4.5% of patients, suggesting a small role for MYBPC3 in this population.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Genetic factors play a significant role in HCM etiology.
  • The MYBPC3 gene is a known contributor to HCM.

Purpose of the Study:

  • To investigate MYBPC3 gene mutations in Han Chinese patients diagnosed with HCM.
  • To identify novel mutations and common polymorphisms within the MYBPC3 gene.

Main Methods:

  • Sixty-six Han Chinese patients with HCM were recruited.
  • Exons of the MYBPC3 gene were amplified using Polymerase Chain Reaction (PCR).
  • Amplified products underwent DNA sequencing for mutation analysis.

Main Results:

  • Four novel MYBPC3 mutations and four common polymorphisms were identified.
  • Specific mutations (Lys301fs, Asp463stop, Gly523Arg, Tyr847His) were detailed with patient phenotypes.
  • MYBPC3 mutations were present in 4.5% of the studied HCM cohort.
  • No MYBPC3 mutations were detected in 100 non-HCM control individuals.

Conclusions:

  • MYBPC3 mutations are found in a small subset of Han Chinese patients with HCM.
  • These findings contribute to understanding the genetic landscape of HCM in this specific population.
Abstract

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...